This can include: In addition to dietary changes, personalized supplementation may be necessary to address specific deficiencies and support thyroid health
What we deemed The Biggest Breakthrough in OSA Since CPAP Bottom Line The FDAs approval of the Wegovy weight-loss pill represents a seminal moment in obesity care transitioning effective GLP-1 pharmacotherapy from injectables to a once-daily tablet
Do not discontinue Wegovy without medical advice, as your clinician may suggest dose adjustments, additional investigations, or alternative management strategies
From a single GLP-1 receptor agonist to dual agonists (tirzepatide) to triple agonists (retatrutide) to a quintuple agonist, the drug design is growing more sophisticated
Some studies have suggested that GLP-1 agonists could be associated with an increased risk of pancreatic issues, which could pose additional complications when considering pregnancy
Studies show that it may improve cholesterol and triglyceride levels, suppress oxidation, reduce blood pressure, and lower fasting blood sugar levels